Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility

Journal of Biological Chemistry

Volumn 288, Issue 17, 2013, Pages 12215-12221

  Krishnan, Harini ^a   Ochoa Alvarez, Jhon A ^a   Shen, Yongquan ^a   Nevel, Evan ^a   Lakshminarayanan, Meenakshi ^b   Williams, Mary C ^b   Ramirez, Maria I ^b   Todd Miller, W ^c   Goldberg, Gary S ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE RESIDUES; ASPARTATE RESIDUE; CELL MIGRATION; MELANOMA CELLS; PKA (PROTEIN KINASE A); TRANSMEMBRANE RECEPTORS; TUMOR BIOMARKERS; TUMOR CELL MOTILITY;

CELL CULTURE; CELLS; MAMMALS; PROTEINS;

AMINO ACIDS;

CYCLIC AMP DEPENDENT PROTEIN KINASE; PODOPLANIN; SERINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SKIN CANCER; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FIBROBLASTS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; PHOSPHORYLATION; SERINE;

MAMMALIA; MUS;

EID: 84876947514     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.C112.446823     Document Type: Article

References (41)

1. Ramirez, M. I., Millien, G., Hinds, A., Cao, Y., Seldin, D. C, and Williams, M. C. (2003) T1a, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 256, 61-72
2. Schacht, V., Ramirez, M. I., Hong, Y. K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A. M., Dvorak, H. F., Oliver, G., and Detmar, M. (2003) T1a/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBOJ. 22, 3546-3556
3. Millien, G., Spira, A., Hinds, A., Wang, J., Williams, M. C., and Ramirez, M. I. (2006) Alterations in gene expression in T1a null lung: a model of deficient alveolar sac development. BMC. Dev. Biol. 6, 35
4. Shen, Y., Chen, C. S., Ichikawa, H., and Goldberg, G. S. (2010) SRC induces podoplanin expression to promote cell migration. J. Biol. Chem. 285, 9649-9656
5. Gandarillas, A., Scholl, F. G., Benito, N., Gamallo, C., and Quintanilla, M. (1997) Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol. Carcinog. 20, 10-18
6. Nose, K., Saito, H., and Kuroki, T. (1990) Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ. 1, 511-518
7. Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D., and Christofori, G. (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9, 261-272
8. Wicki, A., and Christofori, G. (2007) The potential role of podoplanin in tumour invasion. Br. J. Cancer 96, 1-5
9. Raica, M., Cimpean, A. M., and Ribatti, D. (2008) The role of podoplanin in tumor progression and metastasis. Anticancer Res. 28, 2997-3006
10. Astarita, J. L., Acton, S. E., and Turley, S. J. (2012) Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 3, 283
11. Yu, Y., Khan, J., Khanna, C., Helman, L., Meltzer, P. S., and Merlino, G. (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 10, 175-181
12. Asano, E., Maeda, M., Hasegawa, H., Ito, S., Hyodo, T., Yuan, H., Takahashi, M., Hamaguchi, M., and Senga, T. (2011) Role of palladin phosphorylation by extracellular signal-regulated kinase in cell migration. PLoS One 6, e29338
13. Kim, L. C., Song, L., and Haura, E. B. (2009) Src kinases as therapeutic targets for cancer. Nat Rev. Clin. Oncol. 6, 587-595
14. Brábek, J., Constancio, S. S., Siesser, P. F., Shin, N. Y., Pozzi, A., and Hanks, S. K. (2005) Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol. Cancer Res. 3, 307-315
15. Goldberg, G. S., Alexander, D. B., Pellicena, P., Zhang, Z. Y., Tsuda, H., and Miller, W. T. (2003) Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells. J. Biol. Chem. 278, 46533-46540
16. Casnellie, J. E. (1991) Assay of protein kinases using peptides with basic residues for phosphocellulose binding. MethodsEnzymol. 200, 115-120
17. Alexander, D. B., Ichikawa, H., Bechberger, J. F., Valiunas, V., Ohki, M., Naus, C. C., Kunimoto, T., Tsuda, H., Miller, W. T., and Goldberg, G. S. (2004) Normal cells control the growth of neighboring transformed cells independent of gap junctional communication and SRC activity. Cancer Res. 64, 1347-1358
18. Ochoa-Alvarez, J. A., Krishnan, H., Shen, Y., Acharya, N. K., Han, M., McNulty, D. E., Hasegawa, H., Hyodo, T., Senga, T., Geng, J. G., Kosciuk, M., Shin, S. S., Goydos, J. S., Temiakov, D., Nagele, R. G., and Goldberg, G. S. (2012) Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration. PLoS One 7, e41845
19. Shen, Y., Jia, Z., Nagele, R. G., Ichikawa, H., and Goldberg, G. S. (2006) SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res. 66, 1543-1552
20. Goldberg, G. S., Martyn, K. D., and Lau, A. F. (1994) A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol. Carcinog. 11, 106-114
21. Valiunas, V., Bechberger, J. F., Naus, C. C., Brink, P. R., and Goldberg, G. S. (2005) Nontransformed cells can normalize gap junctional communication with transformed cells. Biochem. Biophys. Res. Commun. 333, 174-179
22. Schacht, V., Dadras, S. S., Johnson, L. A., Jackson, D. G., Hong, Y. K., and Detmar, M. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166, 913-921
23. Liang, H., Wu, H., Giorgadze, T. A., Sariya, D., Bellucci, K. S., Veerappan, R., Liegl, B., Acs, G., Elenitsas, R., Shukla, S., Youngberg, G. A., Coogan, P. S., Pasha, T., Zhang, P. J., and Xu, X. (2007) Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am. J. Surg. Pathol. 31, 304-310
24. Durchdewald, M., Guinea-Viniegra, J., Haag, D., Riehl, A., Lichter, P., Hahn, M., Wagner, E. F., Angel, P., and Hess, J. (2008) Podoplanin is a novel fos target gene in skin carcinogenesis. Cancer Res. 68, 6877-6883
25. Martín-Villar, E., Megías, D., Castel, S., Yurrita, M. M., Vilaró, S., and Quintanilla, M. (2006) Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell Sci. 119, 4541-4553
26. Ito, S., Ishii, G., Hoshino, A., Hashimoto, H., Neri, S., Kuwata, T., Higashi, M., Nagai, K., and Ochiai, A. (2012) Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity. Biochem. Biophys. Res. Commun. 422, 194-199
27. Hoshino, A., Ishii, G., Ito, T., Aoyagi, K., Ohtaki, Y., Nagai, K., Sasaki, H., and Ochiai, A. (2011) Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res. 71, 4769-4779
28. Cortez, M. A., Nicoloso, M. S., Shimizu, M., Rossi, S., Gopisetty, G., Molina, J. R., Carlotti, C., Jr., Tirapelli, D., Neder, L., Brassesco, M. S., Scrideli, C. A., Tone, L. G., Georgescu, M. M., Zhang, W., Puduvalli, V., and Calin, G. A. (2010) miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer 49, 981-990
29. Martín-Villar, E., Scholl, F. G., Gamallo, C., Yurrita, M. M., Muñoz-Guerra, M., Cruces, J., and Quintanilla, M. (2005) Characterization of human PA2.26 antigen (T1a-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int. J. Cancer 113, 899-910
30. Martín-Villar, E., Fernández-Muñoz, B., Parsons, M., Yurrita, M. M., Megías, D., Pérez-Gómez, E., Jones, G. E., and Quintanilla, M. (2010) Podoplanin associates with CD44 to promote directional cell migration. Mol. Biol. Cell 21, 4387-4399
31. Funayama, A., Cheng, J., Maruyama, S., Yamazaki, M., Kobayashi, T., Syafriadi, M., Kundu, S., Shingaki, S., Saito, C., and Saku, T. (2011) Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Pathobiology 78, 171-180
32. Mumprecht, V., and Detmar, M. (2009) Lymphangiogenesis and cancer metastasis. J. Cell Mol. Med. 13, 1405-1416
33. Mohammed, R. A., Martin, S. G., Gill, M. S., Green, A. R., Paish, E. C., and Ellis, I. O. (2007) Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am. J. Surg. Pathol. 31, 1825-1833
34. Ito, M., Ishii, G., Nagai, K., Maeda, R., Nakano, Y., and Ochiai, A. (2012) Prognostic impactof cancer-associated stromal cellsin patients with stage I lung adenocarcinoma. Chest 142, 151-158
35. Kawase, A., Ishii, G., Nagai, K., Ito, T., Nagano, T., Murata, Y., Hishida, T., Nishimura, M., Yoshida, J., Suzuki, K., and Ochiai, A. (2008) Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int. J. Cancer 123, 1053-1059
36. Kato, Y., Kaneko, M. K., Kunita, A., Ito, H., Kameyama, A., Ogasawara, S., Matsuura, N., Hasegawa, Y., Suzuki-Inoue, K., Inoue, O., Ozaki, Y., and Narimatsu, H. (2008) Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci. 99, 54-61
37. Nakazawa, Y., Sato, S., Naito, M., Kato, Y., Mishima, K., Arai, H., Tsuruo, T., and Fujita, N. (2008) Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood 112, 1730-1739
38. Chandramohan, V., Bao, X., Kato Kaneko, M., Kato, Y., Keir, S. T., Szafranski, S. E., Kuan, C. T., Pastan, I. H., and Bigner, D. D. (2013) Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. Int. J. Cancer 132, 2339-2348
39. Kato, Y., Vaidyanathan, G., Kaneko, M. K., Mishima, K., Srivastava, N., Chandramohan, V., Pegram, C., Keir, S. T., Kuan, C. T., Bigner, D. D., and Zalutsky, M. R. (2010) Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas. Nucl. Med. Biol. 37, 785-794
40. Honma, M., Minami-Hori, M., Takahashi, H., and Iizuka, H. (2012) Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22. J. Dermatol. Sci. 65, 134-140
41. Krishnan, H., Miller, W. T., and Goldberg, G. S. (2012) SRC points the way to biomarkers and chemotherapeutic targets. Genes Cancer 3, 426-435